Friday, June 2, 2017

BRIEF-Flex Pharma says US Phase 2 trial of FLX-787 in CMT patients to start this summer

* Flex Pharma’S Phase 2 trial with FLX-787 in charcot-marie-tooth endorsed by the inherited neuropathies consortium

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)